Shares of Bioventus (NASDAQ: BVS) fell 14% on Wednesday. The medical device company's stock closed on Tuesday at $3 a share, then opened on Wednesday at $2.90. The stock fell to as low as $2.25 before bouncing back a bit to $2.58 at the close. The stock is down more than 82% this year.

Bioventus focuses on making treatments that enhance the body's natural healing process, such as ultrasound bone healing systems and bone graft materials. The company released its third-quarter earnings report after the market closed on Tuesday. Some of the details were quite positive, so the negative move was a surprise at first. 

The company reported revenue of $137.1 million, up 25.9% year over year with net income of $3.2 million, compared to a net loss of $2.3 million in the same period a year ago. 

Continue reading

Source Fool.com